Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

The association between current enrollment in opioid substitution therapy and risk of providing injection initiation assistance to others over time: a longitudinal cohort study of persons who inject drugs in Toronto, Ontario

FY 2019-20

Summary
The ongoing national overdose crisis is driven, in part, by the increasing supply of illicit, synthetic opioids (including fentanyl and related analogues) and the transition of individuals from misuse of oral medications to injecting opioids (including synthetics and heroin). Correspondingly, experts have called for interventions to both reduce harms associated with opioid use and prevent the expansion of injection drug use practices within vulnerable communities. It is suspected that untreated opioid use disorder (OUD) -- a condition characterized by problematic opioid use resulting in significant impairment or distress -- is widespread and may be contributing to the increasing number of persons who inject drugs (PWID) by: 1) driving persons who have never injected before to seek more intense modes of drug use (i.e., via injection) and 2) increasing the likelihood that PWID (who assist in 90% of injection initiation events, i.e., the first time injection drug use of another) accept or initiate a request to provide injection initiation assistance. Therefore, it is hypothesized that enrolling PWID in opioid substitution therapy (OST) -- which can reduce the cycle of intoxication and withdrawal by blocking the effects of opioids -- will reduce the likelihood they share injection drug use practices with vulnerable individuals. This proposed research aims to: 1) estimate the prevalence of OST enrollment among PWID in Toronto, Ontario using prescription claims data; 2) determine the accuracy of self-reported OST enrollment versus prescription claims; and 3) assess whether PWID who are currently enrolled in OST are less likely to provide injection initiation assistance to others over time. In doing so, the intention is to provide evidence to support (or refute) the presumed protective effect of OST on injection initiation, while quantifying potential treatment gaps.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
417028
Name
Bouck Zachary
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
The association between current enrollment in opioid substitution therapy and risk of providing injection initiation assistance to others over time: a longitudinal cohort study of persons who inject drugs in Toronto, Ontario
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Injection Drug Use; Injection Initiation; Methadone; Naltrexone; Opioid Agonist Therapy; Opioid Substitution Therapy; Overdose; Persons Who Inject Drugs; Persons Who Use Drugs; Suboxone
Abstract
The ongoing national overdose crisis is driven, in part, by the increasing supply of illicit, synthetic opioids (including fentanyl and related analogues) and the transition of individuals from misuse of oral medications to injecting opioids (including synthetics and heroin). Correspondingly, experts have called for interventions to both reduce harms associated with opioid use and prevent the expansion of injection drug use practices within vulnerable communities. It is suspected that untreated opioid use disorder (OUD) -- a condition characterized by problematic opioid use resulting in significant impairment or distress -- is widespread and may be contributing to the increasing number of persons who inject drugs (PWID) by: 1) driving persons who have never injected before to seek more intense modes of drug use (i.e., via injection) and 2) increasing the likelihood that PWID (who assist in 90% of injection initiation events, i.e., the first time injection drug use of another) accept or initiate a request to provide injection initiation assistance. Therefore, it is hypothesized that enrolling PWID in opioid substitution therapy (OST) -- which can reduce the cycle of intoxication and withdrawal by blocking the effects of opioids -- will reduce the likelihood they share injection drug use practices with vulnerable individuals. This proposed research aims to: 1) estimate the prevalence of OST enrollment among PWID in Toronto, Ontario using prescription claims data; 2) determine the accuracy of self-reported OST enrollment versus prescription claims; and 3) assess whether PWID who are currently enrolled in OST are less likely to provide injection initiation assistance to others over time. In doing so, the intention is to provide evidence to support (or refute) the presumed protective effect of OST on injection initiation, while quantifying potential treatment gaps.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bouck, Zachary
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~